体外诊断 (IVD) 趋势与市场最新形势 (2022年11月)

诊断测试产品比以往都重要。检验需求和现行技术、新技术的动向，在体外诊断用医药品市场大部分的领域持续取得进展。新产品和全球医疗支出的变化，主要市场上法规的变更，疾病趋势的要素，持续刷新市场透视。市场中也有引起产业注目的成长领域。其中有新一代定序 (NGS)，个人化医疗，质谱分析等。还有免疫化学，照护现场 (POC) 检验，分子诊断学市场关心也高，成为IVD的未来中核的领域。体外诊断用医药品市场，由于不断的技术创新，继续动态的动向。

本报告提供全球体外诊断 (IVD) 市场最新趋势 (2022年11月现在) 相关分析，整体市场规模趋势预测，及市场主要促进、阻碍因素 (2022年第3季及下半年)，新产品的开发、销售趋势，新型冠状病毒感染疾病 (COVID-19) 的影响，今后的产品开发、市场开拓的可能性等彙整资讯，为您概述为以下内容。

目录

第1章 全球IVD市场 (2022年11月更新)

• IVD市场需求与成长
• COVID-19诊断市场
• COVID-19对市场区隔的影响

第2章 产品趋势与新开发

• 主要的新产品 (2022年第3季):核心IVD产品的销售、开发、趋势
• 临床化学
• 流式细胞技术
• 免疫测量
• 质谱分析
• 分子
• 个人化医疗
• POC
• 定序
• 新型冠状病毒感染疾病 (COVID-19) 相关的主要趋势 (2022年第3季)
• 抗原、抗体
• 分子

第3章 大IVD企业的业绩

• 主要的竞争领导者的最新趋势
• 第3季的企业合併、收购 (M&A) 活动
• Abbott Laboratories
• Becton Dickinson and Co
• bioMérieux SA
• Danaher Corporation
• Hologic, Inc.
• QuidelOrtho Corporation
• Roche Diagnostic
• Siemens Healthineers
• Sysmex Corporation
• Thermo Fisher Scientific

第4章 新机会

• 人工智慧的今后趋势
• 家庭检验
• IVD的微射流
• 远程医疗

Key Questions answered in this report:

• What's Driving Growth in the IVD Market in Q3 and the last half of 2022?

• What Major Trends are Affecting the Market in Q3 and the last half of 2022?

• How Has COVID-19 Impacted and Continued to Impact the Market in Q3 and the last half of 2022?

• What Product Trends and New Developments Will Shape the IVD Market in the last half of 2022?

Diagnostic test products have never been more important. This report is an update of the market for in vitro diagnostics products from Kalorama's analysts to reflect the latest information as of Q3 2022 with a publication date of November 2022.

The demand for testing and movement of current and new technologies has continued to demonstrate gains in most areas of the IVD market. New products, changes in global health spending, regulatory changes in major markets and disease trends are among the factors that produce a constantly evolving market picture. There are some growing segments in the market that have attracted industry attention. Among these are next-generation sequencing (NGS), personalized medicine and mass spectrometry. Immunochemistry, point-of-care (POC) testing, and molecular diagnostics are also segments of great market interest, anticipated to be a core part of the future of IVD. The IVD market remains dynamic, demonstrating constant innovations.

Kalorama Information continues to be diligent in outlining the IVD market and its rapidly changing landscape. Kalorama Information has been and continues to be superior in accessing the market due to the extensive experience of its authors and commitment by the company to present the most accurate data available.

Table of Contents

Chapter 1: Worldwide IVD Market - November 2022 Update

• IVD Market Demand and Growth
  • Figure 1-1: Quarter-by-Quarter Segment Performance Commentary, 2022
  • Table 1-1: Global In Vitro Diagnostic Sales by Product Market, 2022 ($ million) (Clinical Chemistry; Immunoassays - non isotopic: Infectious disease, Other immunos, Blood bank screening, Drugs of Abuse, Diabetes HbA1c - lab; Hematology - Core Lab; Microbiology (ID/AST); Microbiology (molecular); Microbiology - Mass Spectrometry; Coagulation (PT/INR); Coagulation, molecular; Histology/cytology; HPV, molecular; Nucleic acid assays; Blood grouping/typing; Blood bank molecular - NAT Screens; Circulating tumor cells; POC, OTC diabetes; POC, OTC other; POC, professional/hospital; Mass Spectrometry; Other IVD)
  • Figure 1-2: IVD Segment Performance, Q1 2022 - Q4 2022e ($MN)
  • Figure 1-3: IVD Segment Performance, Total Market Value, 2022 ($MN)
• COVID-19 Diagnostic Markets
  • Table 1-2: COVID-19 Product Sales - Immunoassay (Antigen, Serology), Molecular, Rapid - 2022 ($ millions)
• Effect of COVID-19 on Market Segments
  • Table 1-3: IVD Market excluding and with COVID-19, 2022
  • Figure 1-4: IVD Market Distribution by Segment, 2022
  • Figure 1-5: IVD Market by COVID-19 and non-COVID markets, Quarterly Performance, 2022
  • Table 1-4: Global In Vitro Diagnostic Market - YoY Growth 2021-2022
  • Figure 1-6: Global In Vitro Diagnostic Market - YoY Growth 2021-2022

Chapter 2: Product Trends and New Developments

• Selected New - Q3 2022 - Core IVD Product Launches, Developments and Trends
• Clinical Chemistry
• Flow Cytometry
• Immunoassay
• Mass Spectrometry
• Molecular
• Personalized Medicine
• POC
• Sequencing
• Selected COVID-19 Developments - Q3 2022
  • Figure 2-1: COVID-19 Test Market by Type, Q1-Q3 2022 - COVID-19 Testing Wanes
• Antigen/Antibody
• Molecular

Chapter 3: Top IVD Market Participant Results

• Selected Competitive Leader Updates
  • Figure 3-1: IVD Segment Growth by Leading Competitors, Change in Sales 2021-2022
  • Figure 3-2: Changes in Market Distribution for IVD Sales, 2019 - 2022 - Roche and Abbott Battle for #1 Spot
  • Figure 3-3: Comparison of Total Diagnostic Sales for Abbott vs Roche 2020-2022 (in millions $)
• Q3 M&A Activity
  • Table 3-1: IVD-Relevant M&A Activity, 2022
  • Figure 3-4: Count of IVD Industry M&A Deals by Month, 2022
• Abbott Laboratories
  • Table 3-2: Abbott Corporate Summary
• Becton Dickinson and Co
  • Table 3-3: Becton Dickinson Corporate Summary
• bioMérieux SA
  • Table 3-4: bioMérieux Corporate Summary
• Danaher Corporation
  • Table 3-5: Danaher Corporation Summary
• Hologic, Inc.
  • Table 3-6: Hologic Corporate Summary
• QuidelOrtho Corporation
  • Table 3-7: QuidelOrtho Corporate Summary
• Roche Diagnostic
  • Table 3-8: Roche Diagnostic Corporate Summary
• Siemens Healthineers
  • Table 3-9: Siemens Healthineers Corporate Summary
• Sysmex Corporation
  • Table 3-10: Sysmex Corporate Summary
• Thermo Fisher Scientific
  • Table 3-11: Thermo Fisher Scientific Corporate Summary

Chapter 4: New Opportunities

• Artificial Intelligence Future Trends
• At-Home Testing
• Microfluidics in IVD
• Telehealth